Working… Menu

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02943733
Recruitment Status : Recruiting
First Posted : October 25, 2016
Last Update Posted : May 11, 2021
Taiho Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : August 2024